Linked Life Data

20197691

Source:http://linkedlifedata.com/resource/pubmed/id/20197691

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-3
pubmed:dateCreated
2010-4-14
pubmed:abstractText
Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1660-2862
pubmed:author
pubmed:copyrightInfo
Copyright 2010 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
131-5
pubmed:dateRevised
2011-6-9
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Early detection of Alzheimer's disease with PET imaging.
pubmed:affiliation
Department of Psychiatry, Center for Brain Health, School of Medicine, New York, NY, USA.
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't